"The biosimilar market is growing with incredible momentum"

Interview with 4investors (in German only)

Enno Spillner
Chief Financial Officer (CFO)
Formycon AG

In an interview with 4investors, Enno Spillner, CFO of Formycon AG, talks about the rapidly growing biosimilar market, Formycon’s 2025/2029 bond, and how the proceeds will fuel Formycon’s further growth.

You can read the full interview here:

Formycon: „Biosimilar-Markt wächst mit beeindruckender Dynamik“ | 4investors